Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ahmad Abualhaijaa"'
Publikováno v:
Pharmacia, Vol 70, Iss 1, Pp 161-170 (2023)
Antimicrobial agents are one of the most widely used drugs in medicine. In the last fifty years, the misuse of these agents caused the emergence of resistant strains of bacteria that led to an increase in life-threatening infections. The need to deve
Externí odkaz:
https://doaj.org/article/6331758bf0344c17a1920cd2b31e21c1
Autor:
Ahmad Abualhaijaa, Karem H. Alzoubi, Yara Al Tall, Ammar Almaaytah, Majed M Masadeh, Baha'a Al-Rawashdeh
Publikováno v:
Current Pharmaceutical Design. 26:376-385
Background: Multi-drug resistant infections are a growing worldwide health concern. There is an urgent need to produce alternative antimicrobial agents. Objective : The study aimed to design a new hybrid antimicrobial peptide, and to evaluate its ant
Publikováno v:
Molecules, Vol 23, Iss 7, p 1603 (2018)
Current research in the field of antimicrobials is focused on developing novel antimicrobial agents to counteract the huge dilemma that the human population is mainly facing in regards to the rise of bacterial resistance and biofilm infections. Host
Externí odkaz:
https://doaj.org/article/53f8096dabfa453b824ad0a377a944e0
Autor:
Ahmad Abualhaijaa, Mohammad Alsaggar, Majed M Masadeh, Yara Al Tall, Mohammed T Qaoud, Karem H. Alzoubi
Publikováno v:
Current Pharmaceutical Biotechnology. 20:745-754
Background:The over use of current antibiotics and low discovery rate of the new ones are leading to rapid development of multidrug-resistant pathogens worldwide. Antimicrobial peptides have shown promising results against multidrug-resistant bacteri
Autor:
Ahmad Abualhaijaa, Mohammad Alsaggar, Karem H. Alzoubi, Yara Al Tall, Ammar Almaaytah, Majed M Masadeh
Publikováno v:
Infection and Drug Resistance. 12:1035-1045
Background and purpose: The world is heading to a post-antibiotic era where the treatment of bacterial infections will not be possible even with well-known last-line antibiotics. Unfortunately, the emergence of multidrug resistant bacterial strains i
Publikováno v:
Infection and Drug Resistance
Ammar Almaaytah,1 Ahmad Abualhaijaa,2 Obadah Alqudah31Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Applied Biological Sciences, Faculty of Science and Arts, J
Publikováno v:
International Journal of Peptide Research and Therapeutics. 22:497-504
The extensive use of antibiotics for the treatment of human infections during the last few decades has led to a dramatic increase in the emergence of multidrug-resistant bacteria (MDRB) among various bacterial strains. Global research is currently fo
Publikováno v:
Infection and drug resistance. 11
Ammar Almaaytah,1 Mohammed T Qaoud,1 Ahmad Abualhaijaa,2 Qosay Al-Balas,3 Karem H Alzoubi4 1Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Applied Biological Sc
Current research in the field of antimicrobials is focused on the development of novel antibiotics and antimicrobial agents to counteract the huge dilemma that the human population is mainly facing in regards to the rise of bacterial resistance and b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31a7974de21dd95dd117044e389400f4
https://doi.org/10.20944/preprints201805.0356.v1
https://doi.org/10.20944/preprints201805.0356.v1
Autor:
Daniel Knappe, Ammar Almaaytah, Ahmad Abualhaijaa, Mohammed T Qaoud, Ralf Hoffmann, Gubran Khalil Mohammed, Qosay Al-Balas
Publikováno v:
Pharmaceuticals; Volume 11; Issue 1; Pages: 3
Pharmaceuticals
Pharmaceuticals
The recent upsurge of multidrug resistant bacteria (MDRB) among global communities has become one of the most serious challenges facing health professionals and the human population worldwide. Cationic ultrashort antimicrobial peptides (USAMPs) are a